Alcohol use disorders affect 10% of the European population. Alcohol-related liver disease (ALD) is the most common indication for liver transplantation in Slovakia. The aim of this study was to determine the proportion of patients with ALD who received a liver transplant who had alcohol relapsed, and the risk factors for alcohol relapse, as well as to compare clinical outcomes according to relapse.
Background
Behavioral and mental disorders related to alcohol addiction, called alcohol use disorders, affect 10% of European population; one of the consequences of alcohol use disorders is alcoholic liver disease (ALD) that may lead to cirrhosis and is the most common indication for liver transplantation (LTx) in Slovakia [1] [2] [3] . Slovakia ranks fourth in Europe for mortality rate from liver cirrhosis, with ALD being the most prevalent cause [4] . According to the 2018 Global Report on Alcohol and Health, consumption of pure alcohol per capita per year in Slovakia exceeds 11 L (almost double the average of 6.4 L). There are no officially accepted governmental policies to combat alcohol use disorders. Despite conflicting evidence behind the "6-months rule", Slovak patients with a chronic form of ALD would only be eligible for LTx after at least 6 months of abstinence from alcohol consumption documented by the addictologist [5] [6] [7] .
The management of patients referred with decompensated chronic liver disease for consideration of LTx to our center followed standard protocol. We attempt to confirm the etiology and stability of the decompensated state of the liver by the usual spectrum of evaluations: from history taking to hepatic venous pressure gradient and (transjugular) liver biopsy. We attempt to determine if the patient is critical with the diagnosis of ALD. Then we review the data related to the patient's existing abstinence interval and refer the patient to a dedicated addictologist. This expert directly cooperates with our transplant center, and his or her task is to confirm etiology, sobriety, duration of abstinence interval of at least 6 months, and outlook concerning the long-term adherence to abstinence. The only exception is severe acute alcoholic hepatitis not responding to standard treatment in patients fulfilling the criteria of the Lille protocol.
The precise proportion of patients with alcohol use relapse after LTx (a form of alcohol use disorders) is not known; however, according to the literature, the prevalence ranges from 7% to 95% [5, [8] [9] [10] . One of the reasons for this wide variation lies in differing definitions of the term "recurrence" and "relapse." Post-LTx alcohol use relapse may lead to numerous consequences, such as liver graft injury (prevalence up to 17%) [11] , liver graft loss (up to 32%) [12] , and reduced 10-year survival (45% versus 85% in non-relapsers) [11] . The most common alcohol consumption patterns following LTx are occasional drinking (alcohol slip-ups), i.e., consumption of a limited amount of alcohol, followed by re-established abstinence, and harmful drinking, i.e., consumption of 4 or more drinks per day, or drinking for 4 or more successive days (Table 1) [13] .
Risk factors for alcohol use relapse are not well established. The most commonly cited risk factors in the literature are (younger) age, cigarette smoking, mental disorders, non-compliance with regular follow-up, loss of social status (e.g., divorce, bereavement), and unemployment [14] . Our patients are routinely followed according to their clinical status and usually, if stable, on a 3-month follow-up schedule.
In this study, we aimed to determine the proportion of ALD patients who received a transplant who relapsed to alcohol drinking after LTx, and the risk factors for alcohol use relapse. We also compared clinical outcomes according to the presence or absence of alcohol use relapse.
Material and Methods
In this retrospective, single-center study we analyzed the data in consecutive patients who received a liver transplant for the chronic form of ALD during the interval from May 2008 to December 2017. We excluded patients who died during the first month after LTx and patients younger than 18 years of age.
We analyzed the following demographic and clinical variables: age, sex, model for end-stage liver disease (MELD), Child-Pugh score, ascites (grade 1, mild: detected by imaging; grade 2, moderate: physician's objective assessment, 3, large or gross: marked by abdominal distention), hepatic encephalopathy, and survival/mortality. We diagnosed alcohol use relapse based on the clinical suspicion accompanied by the presence of at least 2 of the following criteria. 1) The patient admitted that he or she drinks alcohol on history taking by the physician.
2) The source of this information was the patient's family member or other surrogate living with the patient in the household. 3) Laboratory abnormalities raised the suspicion of alcohol use relapse. We considered suspicious the presence of at least 2 of the following: if the ratio of aspartate aminotransferase (AST) to alanine aminotransferase (ALT) levels was higher than 1; the gamma-glutamyltransferase (GMT) level was above the upper limit of normal (ULN); mean corpuscular volume of erythrocytes (MCV) was above the ULN. A positive blood alcohol test alone sufficed for diagnosing alcohol relapse [15] . We divided the pattern of alcohol use relapse to Definition Harmful (addictive) drinking Consumption of four or more drinks in a day or for 4 or more days in succession
Occasional drinking (slip-up) Consumption of a limited amount of alcohol, followed by re-established abstinence Table 1 . Patterns of relapse to alcohol drinking after liver transplantation [13] .
occasional and harmful drinking according to the literature [13] ( Table 1) . We chose from the literature risk factors of alcohol use relapse which we would also be able to extract from the files of our patients: age, cigarette smoking, mental disorders, non-compliance with regular follow-up, loss of social status (e.g., divorce, bereavement), and unemployment.
We defined liver graft injury as a new onset of elevations above ULN of AST, ALT, GMT, or bilirubin which was then found on at least 1 more measurement 3 months apart. We also recorded liver graft failure and overall mortality.
For statistical analysis, we used legally obtained software MedCalc v.17 (Ostende, Belgium). We present the results of continuous variables as medians and the interquartile ranges results for proportions as numbers of cases and percentages.
Comparison of continuous variables was carried out using the Mann-Whitney test, and the chi-square test was used to compare proportions. To identify factors independently associated with graft injury, all parameters statistically appearing to be associated (i.e., P<0.12) were entered into a backward multivariate logistic regression. We compared overall survival between the patients with and without alcohol use relapse with Kaplan-Meier survival curves. We defined statistical significance by the probability of null-hypothesis inferior to 0.05.
All participants signed the informed consent before liver LTx and agreed with a data publication.
Ethical approval
All procedures involving human participants were approved according to the ethical standards of the institutional research committee, including the , and the mean ChildPugh score was 10.0 points (IQR 9 to 11 points). Summary statistics and study group characteristics are displayed in Table 2 .
We observed alcohol use relapse in 23 out of 89 patients (26%) transplanted for ALD. We did not find any post-transplantation alcohol use in the 153 patients transplanted for non-ALD liver disease (P=0.0001). In 12 patients (52%) the pattern of alcohol use relapse was harmful drinking, and in 11 patients (48%) it was occasional drinking (P=non significance), (Figure 1 ).
In order to determine possible risk factors in our cohort, we compared the risk factor prevalence between relapsers and non-relapsers ( We observed graft injury in 17 patients (73.9%) with alcohol use relapse as compared to 8 patients (12.1%) without relapse (P<0.0001).
In the search for possible risk factors associated with liver graft injury in patients with alcohol use relapse we used univariate analysis and identified the following risk factors: younger age, harmful pattern of drinking, cigarette smoking, loss of social status, and non-compliance with regular appointments (Table 4) . In the multivariate logistic model displayed in In the multivariate logistic model displayed in We did not find a significant difference in mortality during follow-up between patients with or without alcohol use relapse: 2 patients (9%) versus 3 patients (5%), P=0.83.
Comparison of overall survival between patients with and without alcohol use relapse is displayed in Figure 2 . KaplanMeier survival curves revealed no difference in overall survival according to alcohol use relapse after LTx for ALD patients (P=0.93), (Figure 2 ).
Discussion
The most important finding of this single-center retrospective study covering 10 years of our LTx program was the alcohol use relapse rate of 26% seen in patients transplanted for ALD. This rate compares well with other studies [5, [8] [9] [10] 16] . However, some studies found alcohol use also in patients transplanted for other indications than ALD. This finding might be explained by the different inclinations of the ALD and non-ALD cohorts to drink, as was shown in the study by Abosh et al. that only 2% of patients who received a liver transplant for non-ALD drank alcohol after LTx [17] . However, we cannot exclude the possibility that our methodology caused the differences found, as we focused primarily on patients transplanted for ALD. The relatively high prevalence of alcohol use relapse in our cohort among other things adds to the arguments against the clinical usefulness of the 6-month rule [5, 6, 18, 19] . We have adopted this rule for 2 historical reasons: as a part of the protocol from our mentoring institution and because it harmonized with the atmosphere in the professional and lay community at that time. In light of our results, however, we will have to reconsider. The most probable next step will be to scrutinize the feasibility in this context of the Lille model approach which we already adopted for the patients with acute alcoholic hepatitis [20] .
The impact of alcohol use relapse on liver graft injury over time (73.9% versus 12.1%, P<0.0001) concurs with the available data [21] , but the non-significant impact on mortality does not. According to available literature, the 1-year survival rate in patients after LTx due to ALD is at least as good as in other etiologies and reaches 93% [1, [22] [23] [24] . However, with the alcohol use relapse, especially to harmful drinking, the mortality rate increases [25, 26] . This discrepancy might be explained by a rather small number of patients and relatively short median follow-up time [11, 12] as was the case in our study The median time (in days from LTx) at which we determined the alcohol use relapse was longer in patients with relapse as compared to patients without relapse (1228.0 days versus 2595.0 days, P=0,0006); in fact, the time from LTx was an independent predictor of alcohol relapse. The design of our study allowed us to evaluate only the cumulative rate of alcohol relapse, but not the temporal trends in more detail. However, patients that relapsed had a median time post LTx of over 7 years, which might suggest that the follow-up program of psychological and social support should be long-term, possibly indefinite. The evolution of liver graft injury over time has been addressed in several studies [15, 27, 28] .
Of potential risk factors for alcohol relapse listed in the literature [5, 23, 25] , several associations also appeared in our study: cigarette smoking, loss of social status, and non-adherence with regular follow-up All of these risk factors will be used at our center immediately as warning signals and we will implement them into the daily clinical practice. Also, we will address them in a prospective study. These risk factors could serve as a risk-stratification measure helping us to provide patients at risk with more intensive management by the addictology experts and social support team [18, 25, [29] [30] [31] [32] [33] [34] . Several studies have suggested that younger age and female sex is related to increased alcohol relapse rates [18, 21, 32, 35] . Our patients with alcohol use relapse were almost 3.5 years younger, but the difference was not statistically significant. Limitations of our study were the retrospective design, the single-center setting, and the relatively low number of patients. However, a single-center report provides results with unified selection criteria for LTx and unified diagnostic and management protocols. The obvious limitations of our study were the lack of liver biopsies in all patients with alcohol use relapse and the inability to determine the exact time of first relapse.
To the best of our knowledge, this is the first study of its kind in Slovakia, and the second in the published literature from the Central European region [35] .
Conclusions
We documented alcohol use relapse in 26% of patients transplanted for ALD; this relatively high rate was comparable with data from the literature. We identified several risk factors associated with alcohol use relapse: cigarette smoking, loss of social status, and non-compliance with regular follow-ups. We will use these risk factors as a trigger for intervention in our center. In our study, alcohol use relapse was associated with liver graft injury but not with mortality, probably due to the limited follow-up time and sample size of our study. These study findings allow us to move forward in methods for data collection, risk stratification of waitlisted patients with ALD, as well as with a more intensive and directed post-transplantation psychological and social support.
